Cholecalciferol complexation with hydroxypropyl-β-cyclodextrin (HPBCD) and its molecular dynamics simulation

被引:13
作者
Wang, Fang [1 ]
Yu, Wenbo [1 ,2 ]
Popescu, Carmen [3 ]
Ibrahim, Ahmed Ashour [1 ]
Yu, Dongyue [1 ]
Pearson, Ryan [1 ]
MacKerell, Alexander D., Jr. [1 ,2 ]
Hoag, Stephen W. [1 ]
机构
[1] Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, 20 N Pine St, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Pharm, Comp Aided Drug Design Ctr, Baltimore, MD 21201 USA
[3] Roquette Amer Inc, Geneva, IL USA
关键词
Cholecalciferol (vitamin D3); hydroxypropyl-beta-cyclodextrin (HPBCD); complex; molecular modeling; molecular dynamic (MD) simulations; GENERAL FORCE-FIELD; INCLUSION COMPLEXATION; DRUG; SOLUBILIZATION; ENHANCEMENT; DISSOLUTION; BIOAVAILABILITY; EXCIPIENTS; SYSTEM; TOOL;
D O I
10.1080/10837450.2022.2064492
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The focus of the current study is to investigate cholecalciferol (vitamin D3) solubilization by hydroxypropyl-beta-cyclodextrin (HPBCD) complexation through experimental and computational studies. Phase solubility diagram of vitamin D3 (completely insoluble in water) has an A(p) profile revealing a deviation from a linear regression with HPBCD concentration increase. Differential scanning calorimetry (DSC) is the best tool to confirm complex formation by disappearance of cholecalciferol exothermic peak in cholecalciferol-HPBCD complex thermogram, due to its amorphous state by entering HPBCD inner hydrophobic cavity, similarly validated by Fourier-transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD). A(p) solubility diagram profile can be associated with cholecalciferol-HPBCD complex instability in liquid phase requiring spray drying to bring it to a solid dispersion state (always more stable) illustrated by scanning electron microscopy (SEM). Computational studies led to a deeper understanding and clarification, at molecular level, of the interactions within cholecalciferol-HPBCD complex. Thermodynamics and geometry of the complex were investigated by molecular dynamics (MD) simulation.
引用
收藏
页码:389 / 398
页数:10
相关论文
共 58 条
[1]  
[Anonymous], 2021, VITAMIN FACT SHEET H
[2]  
[Anonymous], 2022, Molecular Operating Environment (MOE)
[3]  
[Anonymous], 2004, ESTIMATION PROGRAM I
[4]  
[Anonymous], 2022, HSDB CHOLECALCIFEROL
[5]   Application of Pharmaceutical QbD for Enhancement of the Solubility and Dissolution of a Class II BCS Drug using Polymeric Surfactants and Crystallization Inhibitors: Development of Controlled-Release Tablets [J].
Basalious, Emad B. ;
El-Sebaie, Wessam ;
El-Gazayerly, Omaima .
AAPS PHARMSCITECH, 2011, 12 (03) :799-810
[6]   Cyclodextrins as pharmaccutical solubilizers [J].
Brewster, Marcus E. ;
Loftsson, Thorsteinn .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :645-666
[7]   Development of Improved Empirical Models for Estimating the Binding Constant of a β-Cyclodextrin Inclusion Complex [J].
Chari, Ravi ;
Qureshi, Farooq ;
Moschera, John ;
Tarantino, Ralph ;
Kalonia, Devendra .
PHARMACEUTICAL RESEARCH, 2009, 26 (01) :161-171
[8]   PARTICLE MESH EWALD - AN N.LOG(N) METHOD FOR EWALD SUMS IN LARGE SYSTEMS [J].
DARDEN, T ;
YORK, D ;
PEDERSEN, L .
JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (12) :10089-10092
[9]   SOLVENT-INDUCED FORCES BETWEEN 2 HYDROPHILIC GROUPS [J].
DURELL, SR ;
BROOKS, BR ;
BENNAIM, A .
JOURNAL OF PHYSICAL CHEMISTRY, 1994, 98 (08) :2198-2202
[10]  
Feldman D, 2004, VITAMIN D